ArticleJournal of family medicine and primary care2025
Topical corticosteroid phobia among the general population in the western region of Saudi Arabia.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Topical Corticosteroid-Related Concerns and Phobic Behaviors in Saudi Arabia: A Cross-Sectional Investigation.Healthcare (Basel, Switzerland) · 2026Article
- Corticosteroid Phobia in Patients with Atopic Dermatitis: A Narrative Review.Clinical, cosmetic and investigational dermatology · 2026Review
- Development and Rasch Validation of the Parental Topical Corticosteroid Phobia Scale (PTCPS) in Pediatric Eczema Care.Healthcare (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: Topical corticosteroids (TCS) are some of the most prescribed medications in the field of dermatology. The awareness about the side effects of TCS grew exponentially, leading to a state of fear among the general population. This led to a fear of steroid use, which contributed to a serious compromise in patients' adherence. Aims: Our study aims to assess the prevalence of topical corticosteroid phobia in the region, as this could help in creating awareness programs regarding the safety of TCS, thereby improving the patient's compliance and reducing the burden of non-adherence to treatment. Setting and Design: This cross-sectional study was conducted among Saudi Arabia's western region's general population between January and June 2023. Methods: The questionnaire which consists of four sections, was distributed throughout social media sites. Statistical analysis was performed using RStudio (R version 4.3.1). Data was expressed using frequencies and percentages (categorical variables). Corticophobia was assessed using 15 items, of which responses were collected on a five-point Likert scale. An overall corticophobia score was computed by summing up the values of coded items. The final score ranged from 15 to 75. A Results: A total of 549 participants' answers were analyzed. Regarding participants' knowledge and beliefs, the overall cohort's median topical steroid phobia score was 52. Conclusion: Our findings indicate that most participants fear the usage of topical corticosteroids (80.7%). By acknowledging the fear levels of TCS in society, educational programs can be implemented to reduce this fear and help these individuals to enhance treatment adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.